Skip to main content
Login
Contact
Subscribe
Search form
Search
The Observer News Enterprise
Home
Forms
News
Sports
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Classifieds
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aethlon Medical
(NQ:
AEMD
)
2.607
USD
-0.043 (-1.61%)
Streaming Delayed Price
Updated: 1:34 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Aethlon Medical
< Previous
1
2
3
4
5
6
Next >
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
January 06, 2021
Guy Cipriani brings over 17 years of biotech and pharma business development experience to his role as Senior Vice President and Chief Business Officer of Aethlon
From
PR Newswire
Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference
January 04, 2021
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today announced that the company will...
From
PR Newswire
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer
December 16, 2020
Study is evaluating the HEMOPURIFIER® for reducing cancer-associated exosomes prior to the administration of standard-of-care KEYTRUDA®
From
PR Newswire
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
November 03, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, announced today the appointment of Charles...
From
PR Newswire
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update
October 28, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for...
From
PR Newswire
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
October 19, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its second quarter fiscal...
From
PR Newswire
Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that Timothy C....
From
PR Newswire
Aethlon Medical to Present at the LD Micro 500 Virtual Conference
August 27, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that CEO, Timothy C....
From
PR Newswire
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
August 11, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for...
From
PR Newswire
Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer
August 06, 2020
Up to $3.5 million in funding over 5 years for trials and research at multiple institutions
From
PR Newswire
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020
August 04, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter fiscal year...
From
PR Newswire
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
June 25, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for...
From
PR Newswire
Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting
June 22, 2020
The Hemopurifier effectively clears plasma exosomes that originate from diverse types of cancer
From
PR Newswire
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
June 18, 2020
Allows for enrollment of up to 40 subjects in up to 20 centers
From
PR Newswire
Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020
June 16, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal...
From
PR Newswire
Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
March 24, 2020
Corresponding Patents Previously Issued in the United States and Canada
From
PR Newswire
Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires
February 24, 2020
Stock to resume trading
From
PR Newswire
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
February 10, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for...
From
PR Newswire
Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock
February 10, 2020
NASDAQ:AEMD) -- On February 7, 2020, the Securities and Exchange Commission (SEC) issued an Order of Suspension of Trading (the "SEC Order"), temporarily suspending trading in Aethlon Medical, Inc....
From
PR Newswire
Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020
February 06, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its third quarter fiscal year...
From
PR Newswire
Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months
January 30, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months
January 30, 2020
FN Media Group Presents USA News Group Market Commentary
From
PR Newswire
Several Drugmakers are Racing to Create and Test a Vaccine for China’s Deadly Coronavirus
January 29, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus
January 29, 2020
FN Media Group Presents USA News Group Market Commentary
From
PR Newswire
Agency Taps Australia to Create a Coronavirus Vaccine with ‘Unprecedented Speed’
January 28, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Agency Taps Australia to Create a Coronavirus Vaccine With 'Unprecedented Speed'
January 28, 2020
FN Media Group Presents USA News Group Market Commentary
From
PR Newswire
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
January 23, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
January 23, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering
January 22, 2020
Aethlon Medical, Inc. (Nasdaq:AEMD) ("Aethlon" or the "Company"), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today...
From
PR Newswire
Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer
January 22, 2020
FN Media Group Presents USA News Group Market Commentary
From
PR Newswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.